New TYK2 Inhibitors for Psoriasis Achieve High Clearance Rates in Randomized Trials
(MedPage Today) -- DENVER -- Two drug candidates to expand oral therapy options for psoriasis had similar and consistent performances ...
(MedPage Today) -- DENVER -- Two drug candidates to expand oral therapy options for psoriasis had similar and consistent performances ...
(MedPage Today) -- The FDA has approved the first oral interleukin (IL)-23-targeted therapy for plaque psoriasis, Johnson & Johnson announced. ...
(MedPage Today) -- For Medicaid beneficiaries with psoriasis, biologic treatment patterns differed significantly among racial and ethnic groups, according to ...
(MedPage Today) -- "Is it something I ate?" For years, dermatologists have waved off that question, but new data suggest ...
© 2025 PickByDoc. All rights reserved. PickByDoc is a medical news & health awareness platform.